Ethical frameworks in clinical research processes during COVID-19: a scoping review
Objectives In response to the COVID-19 pandemic there have been significant developments in research, its conduct and the supporting ethical framework. While many protocols have been delayed, halted or modified, other research efforts have been accelerated, generating controversy. The goal of this p...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-07-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/11/7/e047076.full |
id |
doaj-e3c91c157690489db6792a5db944016d |
---|---|
record_format |
Article |
spelling |
doaj-e3c91c157690489db6792a5db944016d2021-08-07T16:33:32ZengBMJ Publishing GroupBMJ Open2044-60552021-07-0111710.1136/bmjopen-2020-047076Ethical frameworks in clinical research processes during COVID-19: a scoping reviewAmit M Oza0Qin Liu1Ainhoa Madariaga2Lawrence Kasherman3Lisa Wang4Michelle McMullen5Katherine Karakasis6Luisa Bonilla7Shiru (Lucy) Liu8Rouhi Fazelzad9Ann M Heesters10Division of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, CanadaDivision of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, CanadaDivision of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, CanadaDivision of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, CanadaUniversity of Toronto, Toronto, Ontario, CanadaDivision of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, CanadaDivision of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, CanadaDivision of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, CanadaDivision of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, CanadaDivision of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, CanadaUniversity of Toronto, Toronto, Ontario, CanadaObjectives In response to the COVID-19 pandemic there have been significant developments in research, its conduct and the supporting ethical framework. While many protocols have been delayed, halted or modified, other research efforts have been accelerated, generating controversy. The goal of this paper is to determine the rates of references surrounding the ethical oversight of research as reported in current COVID-19-related research publications.Design Scoping review.Setting Population-based observational or interventional studies from December 2019 to May 2020 with sample size of two or more. Studies were searched through electronic databases including Medline, EMBASE, and Cochrane CENTRAL Register of Controlled Trials.Participants Eligibility criteria included participants within published studies who tested positive for COVID-19.Main outcomes and measures Data were extracted and charting methods included taking note of references to ethical frameworks, institutional review board (IRB), ethics committee (EC) or research ethics board (REB) involvement, consent processes, and other variables.Results 11 556 articles were screened, with 656 included in the final analysis. References to ethics were present in 530 (80.8%) studies, with 491 (74.8%) involving IRB/ECs/REBs and 126 (19.2%) not referencing ethics. Consent processes were outlined in 201 (30.6%) studies, with 198 (30.2%) reporting that they obtained consent waivers, however, 257 (39.2%) did not mention consent at all. Differences (p<0.001) in ethics-related references were apparent when analysed by continent, publication type, sample size and IF.Conclusions The majority of published articles pertaining to COVID-19 research made mention of ethical considerations, however, national and regional variations in research ethics review requirements introduce heterogeneity between studies and raise important questions about the conduct of scientific research during global public emergencies.Trial registration number Open Science Framework: https://osfio/z67wb.https://bmjopen.bmj.com/content/11/7/e047076.full |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Amit M Oza Qin Liu Ainhoa Madariaga Lawrence Kasherman Lisa Wang Michelle McMullen Katherine Karakasis Luisa Bonilla Shiru (Lucy) Liu Rouhi Fazelzad Ann M Heesters |
spellingShingle |
Amit M Oza Qin Liu Ainhoa Madariaga Lawrence Kasherman Lisa Wang Michelle McMullen Katherine Karakasis Luisa Bonilla Shiru (Lucy) Liu Rouhi Fazelzad Ann M Heesters Ethical frameworks in clinical research processes during COVID-19: a scoping review BMJ Open |
author_facet |
Amit M Oza Qin Liu Ainhoa Madariaga Lawrence Kasherman Lisa Wang Michelle McMullen Katherine Karakasis Luisa Bonilla Shiru (Lucy) Liu Rouhi Fazelzad Ann M Heesters |
author_sort |
Amit M Oza |
title |
Ethical frameworks in clinical research processes during COVID-19: a scoping review |
title_short |
Ethical frameworks in clinical research processes during COVID-19: a scoping review |
title_full |
Ethical frameworks in clinical research processes during COVID-19: a scoping review |
title_fullStr |
Ethical frameworks in clinical research processes during COVID-19: a scoping review |
title_full_unstemmed |
Ethical frameworks in clinical research processes during COVID-19: a scoping review |
title_sort |
ethical frameworks in clinical research processes during covid-19: a scoping review |
publisher |
BMJ Publishing Group |
series |
BMJ Open |
issn |
2044-6055 |
publishDate |
2021-07-01 |
description |
Objectives In response to the COVID-19 pandemic there have been significant developments in research, its conduct and the supporting ethical framework. While many protocols have been delayed, halted or modified, other research efforts have been accelerated, generating controversy. The goal of this paper is to determine the rates of references surrounding the ethical oversight of research as reported in current COVID-19-related research publications.Design Scoping review.Setting Population-based observational or interventional studies from December 2019 to May 2020 with sample size of two or more. Studies were searched through electronic databases including Medline, EMBASE, and Cochrane CENTRAL Register of Controlled Trials.Participants Eligibility criteria included participants within published studies who tested positive for COVID-19.Main outcomes and measures Data were extracted and charting methods included taking note of references to ethical frameworks, institutional review board (IRB), ethics committee (EC) or research ethics board (REB) involvement, consent processes, and other variables.Results 11 556 articles were screened, with 656 included in the final analysis. References to ethics were present in 530 (80.8%) studies, with 491 (74.8%) involving IRB/ECs/REBs and 126 (19.2%) not referencing ethics. Consent processes were outlined in 201 (30.6%) studies, with 198 (30.2%) reporting that they obtained consent waivers, however, 257 (39.2%) did not mention consent at all. Differences (p<0.001) in ethics-related references were apparent when analysed by continent, publication type, sample size and IF.Conclusions The majority of published articles pertaining to COVID-19 research made mention of ethical considerations, however, national and regional variations in research ethics review requirements introduce heterogeneity between studies and raise important questions about the conduct of scientific research during global public emergencies.Trial registration number Open Science Framework: https://osfio/z67wb. |
url |
https://bmjopen.bmj.com/content/11/7/e047076.full |
work_keys_str_mv |
AT amitmoza ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview AT qinliu ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview AT ainhoamadariaga ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview AT lawrencekasherman ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview AT lisawang ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview AT michellemcmullen ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview AT katherinekarakasis ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview AT luisabonilla ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview AT shirulucyliu ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview AT rouhifazelzad ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview AT annmheesters ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview |
_version_ |
1721217000707981312 |